These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36435710)
1. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? Alsyouf M; Ladi-Seyedian SS; Konety B; Pohar K; Holzbeierlein JM; Kates M; Willard B; Taylor JM; Liao JC; Kaimakliotis HZ; Porten SP; Steinberg GD; Tyson MD; Lotan Y; Daneshmand S; Urol Oncol; 2023 Feb; 41(2):109.e9-109.e14. PubMed ID: 36435710 [TBL] [Abstract][Full Text] [Related]
2. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary? Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963 [No Abstract] [Full Text] [Related]
3. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review. Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145 [TBL] [Abstract][Full Text] [Related]
4. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
5. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J; Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749 [TBL] [Abstract][Full Text] [Related]
6. Early Photodynamic Diagnosis Cystoscopy After Bacillus Calmette-Guérin (BCG) Induction for High-Risk Nonmuscle Invasive Bladder Cancer Significantly Increased the Detection of BCG Refractory Tumors. Morelli M; Baboudjian M; Vanacore D; Gondran-Tellier B; McManus R; Karsenty G; Lechevallier E; Montanari E; Boissier R J Endourol; 2021 Dec; 35(12):1824-1828. PubMed ID: 34107773 [No Abstract] [Full Text] [Related]
7. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer. Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis. Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149 [No Abstract] [Full Text] [Related]
10. Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group. Yuk HD; Kim JK; Jeong CW; Kwak C; Kim HH; Ku JH Biomed Res Int; 2018; 2018():9432606. PubMed ID: 30271788 [TBL] [Abstract][Full Text] [Related]
11. 'Real-life experience': recurrence rate at 3 years with Hexvix Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385 [TBL] [Abstract][Full Text] [Related]
12. Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results. de la Rosette J; Martov A; Hurle R; Favre G; Mamoulakis C; Castanheira de Oliveira M; Stenzl A; Linares-Espinós E; Trelles Guzmán CR; Gravas S; Knoll T; Boz MY; Herrmann T; Laguna P World J Urol; 2022 Mar; 40(3):727-738. PubMed ID: 34741631 [TBL] [Abstract][Full Text] [Related]
13. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study. Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814 [TBL] [Abstract][Full Text] [Related]
14. Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer. Zapała P; Dybowski B; Poletajew S; Białek Ł; Niewczas A; Radziszewski P World J Surg Oncol; 2018 Jan; 16(1):6. PubMed ID: 29334958 [TBL] [Abstract][Full Text] [Related]
15. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer. Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study. Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571 [TBL] [Abstract][Full Text] [Related]
18. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843 [TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis. Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832 [TBL] [Abstract][Full Text] [Related]
20. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]